ECFG takes minority stake in Dutch eye-care maker Oté
What's the deal? Investment firm ECFG has acquired a minority stake in Oté PharmaDealroom has a profile for this one. Try Dealroom →, an Uden-based developer and manufacturer of contact lens care and eye care products. The late-stage deal, announced in November 2026, comes through the ECFG Ventures III fund. Financial details were not disclosed.
What does Oté do? Founded in 1979, the former family business makes contact lens solutions, eye drops, eye sprays, and related products from its development and manufacturing facilities in Uden. It serves customers across Europe and the United States, selling both under its own brands and as a private-label producer for international optical retail chains.
What's the money for? The two parties want to expand Oté's international market position and strengthen its operations. ECFG, an active minority shareholder, will work with management to optimise manufacturing and logistics processes and further professionalise the organisation.
Why now? Oté's leadership has recently restructured. Rob Oorthuizen, a second-generation family member and long-time managing director, now focuses on business development and international customer relationships following the appointment of chief executive officer Jeroen Walraven, who leads the company's growth.
What's the endgame? ECFG wants to ready Oté's production organisation for further international expansion, using investments in processes, organisation, and innovation to build a base for scalable growth.
“Oté is well positioned for further international growth, thanks to its specialist knowledge, high-quality manufacturing and long-standing customer relationships,” said Hans Bloemen, managing director at ECFG. “This is exactly the type of company we aim to invest in through Ventures III.”
The signal: The deal fits ECFG Ventures III's focus on technology-driven companies with international growth potential, following its earlier investment in Optics11 LifeDealroom has a profile for this one. Try Dealroom →. With strict quality and certification requirements raising barriers to entry, specialist producers like Oté hold an advantage as demand for eye care grows alongside ageing populations.
Read more: linkmagazine.nl
Image credit: Oté Pharma
